Literature DB >> 7872584

Increased incidence of aortic aneurysm and dissection in giant cell (temporal) arteritis. A population-based study.

J M Evans1, W M O'Fallon, G G Hunder.   

Abstract

OBJECTIVE: To determine the frequency of aneurysm and dissection of the aorta in patients with giant cell arteritis and to assess the effects of these events on these patients.
DESIGN: Population-based cohort study.
SETTING: A multispecialty and a primary care clinic in southern Minnesota. PATIENTS: 96 residents of Olmsted County, Minnesota, who developed giant cell arteritis between 1950 and 1985. The presence of aortic aneurysm, dissection, or both was confirmed using computed tomography, ultrasonography, angiography, or autopsy.
RESULTS: 11 of the 96 patients were found to have thoracic aortic aneurysms. In 2 of these patients, the aneurysms were detected when giant cell arteritis was diagnosed. In the remaining 9 patients, the aneurysms occurred a median of 5.8 years after giant cell arteritis was diagnosed. Six of the 11 died suddenly of acute thoracic aortic dissection. Five patients who did not have thoracic aortic aneurysms developed isolated abdominal aortic aneurysms a median of 2.5 years after giant cell arteritis was diagnosed. The incidence of thoracic aortic aneurysm in patients with giant cell arteritis was 999 per 100,000 person-years; the incidence of abdominal aortic aneurysm in these patients was 555 per 100,000 person-years. Compared with all persons of the same age and sex living in Olmsted County, patients with giant cell arteritis were 17.3 times (95% Cl, 7.9 to 33.0) more likely to develop thoracic aortic aneurysm and 2.4 times (Cl, 0.8 to 5.5) more likely to develop isolated abdominal aortic aneurysm.
CONCLUSIONS: Giant cell arteritis is associated with a markedly increased risk for the development of aortic aneurysm, which is often a late complication and may cause death.

Entities:  

Mesh:

Year:  1995        PMID: 7872584     DOI: 10.7326/0003-4819-122-7-199504010-00004

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  88 in total

1.  Formation of new vasa vasorum in vasculitis. Production of angiogenic cytokines by multinucleated giant cells.

Authors:  M Kaiser; B Younge; J Björnsson; J J Goronzy; C M Weyand
Journal:  Am J Pathol       Date:  1999-09       Impact factor: 4.307

2.  Giant Cell Arteritis.

Authors: 
Journal:  Curr Treat Options Cardiovasc Med       Date:  2000-06

Review 3.  Giant cell arteritis.

Authors:  J M Calvo-Romero
Journal:  Postgrad Med J       Date:  2003-09       Impact factor: 2.401

4.  Gastric bleeding in giant cell arteritis.

Authors:  Austin Childress; Thomas J Kwarcinski; Joseph Scott H Bittle; Clayton Trimmer
Journal:  Proc (Bayl Univ Med Cent)       Date:  2020-10-15

5.  Cough as the presenting symptom of large vessel vasculitis.

Authors:  B Van der Schueren; M Lambert
Journal:  Clin Rheumatol       Date:  2005-01-14       Impact factor: 2.980

6.  Integrated head-thoracic vascular MRI at 3 T: assessment of cranial, cervical and thoracic involvement of giant cell arteritis.

Authors:  T A Bley; O Wieben; M Uhl; N Miehle; M Langer; J Hennig; M Markl
Journal:  MAGMA       Date:  2005-08-29       Impact factor: 2.310

Review 7.  Giant cell arteritis.

Authors:  Todd J Schwedt; David W Dodick; Richard J Caselli
Journal:  Curr Pain Headache Rep       Date:  2006-12

Review 8.  [New pathogenetic aspects in primary systemic vasculitides].

Authors:  P Lamprecht
Journal:  Internist (Berl)       Date:  2009-03       Impact factor: 0.743

9.  The value of [18F]FDG-PET in the diagnosis of large-vessel vasculitis and the assessment of activity and extent of disease.

Authors:  Martin A Walter; Ralph A Melzer; Christian Schindler; Jan Müller-Brand; Alan Tyndall; Egbert U Nitzsche
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-03-04       Impact factor: 9.236

10.  Large-vessel involvement in giant cell arteritis: a population-based cohort study of the incidence-trends and prognosis.

Authors:  Tanaz A Kermani; Kenneth J Warrington; Cynthia S Crowson; Steven R Ytterberg; Gene G Hunder; Sherine E Gabriel; Eric L Matteson
Journal:  Ann Rheum Dis       Date:  2012-12-19       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.